Raja Dashti

Raja Dashti

Auto-generated profile, based on publicly available information

Raja Dashti

Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
MAMohammed Al‐Jarallah
Mohammed Al‐Jarallah
RRRajesh Rajan
Rajesh Rajan
RDRaja Dashti
Raja Dashti
AAAhmad Alsaber
Ahmad Alsaber
JPJiazhu Pan
Jiazhu Pan
MAMoudhi Alroomi
Moudhi Alroomi
This study is done to estimаte in‐hоsрitаl mоrtаlity in раtients with severe асute resрirаtоry syndrоme соrоnаvirus 2 (SАRS‐СоV‐2) strаtified by Vitamin‐D (Vit‐D) levels. Раtients were strаtified ассоrding tо by serum 25‐hydroxy‐vitamin D (25(OH)Vit‐D) levels intо twо grоuрs, that is, 25(OH)Vit‐D less thаn 40 nmol/L аnd 25(OH)Vit‐D greаter thаn 40 nmol/L. А tоtаl оf 231 раtients were inсluded. Оf these, 120 (50.2%) оf the раtients hаd 25(OH)Vit‐D levels greаter thаn 40 nmol/L. The meаn аge wаs 49 ± 17 yeаrs, аnd 67% оf the раtients were mаles. The mediаn length оf оverаll hоsрitаl stаy wаs 18 [6; 53] dаys. The remаining 119 (49.8%) раtients hаd а 25(OH)Vit‐D less thаn 40 nmol/L. Vitamin D levels were seen as deficient in 63% of patients, insufficient in 25% and normal in 12%. Оverаll mоrtаlity wаs 17 раtients (7.1%) but statistically not signifiсаnt among the grоuрs (p = 0.986). The Kарlаn–Meier survivаl аnаlysis shоwed no significance based on an alpha of 0.05, LL = 0.36, df = 1, p = 0.548, indicating Vitamin_D_Levels was not able to adequately predict the hazard of Mortality. In this study, serum 25(OH)Vit‐D levels were found have no significance in terms of predicting the in‐hоsрitаl mortality in раtients with SАRS‐СоV‐2.

5 May 2021 in eJHaem
Verified
Journal Article
Open access
PDF file
MAMohammed Al‐Jarallah
Mohammed Al‐Jarallah
RRRajesh Rajan
Rajesh Rajan
AAAhmad Alsaber
Ahmad Alsaber
JPJiazhu Pan
Jiazhu Pan
AAAhmad T. Al‐Sultan
Ahmad T. Al‐Sultan
KZKobalava D. Zhanna
Kobalava D. Zhanna
This study is to estimate in‐hospital mortality in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) patients stratified by hemoglobin (Hb) level. Patients were stratified according to hemoglobin level into two groups, that is, Hb 100 g/L. A total of 6931 patients were included. Of these, 6377 (92%) patients had hemoglobin levels >100 g/L. The mean age was 44 ± 17 years, and 66% of the patients were males. The median length of overall hospital stay was 13 days [2; 31]. The remaining 554 (8%) patients had a hemoglobin level <100 g/L. Overall mortality was 176 patients (2.54%) but was significantly higher in the group with hemoglobin levels 100 g/L (52, 0.82%). Risk factors associated with increased mortality were determined by multivariate analysis. The Kaplan‐Meier survival analysis showed hemoglobin as a predictor of mortality. Cox proportional hazards regression coefficients for hemoglobin for the HB ≤ 100 category of hemoglobin were significant, B = 2.79, SE = 0.17, and HR = 16.34, p < 0.001. Multivariate logistic regression showed Hb < 100 g/L had a higher cumulative all‐cause in‐hospital mortality (22.4% vs. 0.8%; adjusted odds ratio [aOR], 0.33; 95% [CI]: [0.20–0.55]; p < 0.001). In this study, hemoglobin levels <100 g/L were found to be an independent predictor of in‐hospital mortality.

1 January 2024 in Annals of Clinical Cardiology
Verified
Journal Article
Open access
NSNayef Al Sharekh
Nayef Al Sharekh
MJMohammed Al Jarallah
Mohammed Al Jarallah
RDRaja Dashti
Raja Dashti
BBBassam Bulbanat
Bassam Bulbanat
MRMustafa Ridha
Mustafa Ridha
GTGhazaal Alavi Tabatabaei
Ghazaal Alavi Tabatabaei
Background: Heart failure (HF) is a prevalent condition in our society, frequently accompanied by various interacting comorbidities. Among these, brain-related comorbidities such as stroke and transient ischemic attack (TIA) play a crucial role in exacerbating the severity of HF. The relationship between cerebrovascular accidents (CVAs) and HF across different left ventricular ejection fraction (LVEF) levels is not well understood. Objectives: This study aims to assess the impact of CVA including stroke and TIA on mortality and morbidity in patients with acute heart failure (AHF) stratified by LVEF. Methods: We conducted an analysis of consecutive patients admitted to 47 hospitals in seven Middle Eastern countries (Saudi Arabia, Oman, Yemen, Kuwait, United Arab Emirates, Qatar, and Bahrain) with AHF from February to November 2012 with AHF who were enrolled in a multinational registry of patients with HF. The study population consisted of patients with CVA and AHF, categorized into three groups based on EF: HF patients with preserved EF (HFpEF) (250%), HF patients with reduced EF (HFrEF) (<40%), and HF patients with mid-range EF (HFmrEF) (40%–49%). Univariate and multivariate statistical techniques were employed for the analysis. Results: Our study involved 370 patients, averaging 66.4 ± 13.2 years. In-hospital mortality for CVA and AHF patients was 8.4% (n = 31). Patients in different ranges of LVEF experienced comparable rates of hospitalization and mortality at both the 3-month and 12-month intervals. Left atrial enlargement (odd ratio [OR]: 3.27, 95% confidence interval [CI]: 1.33–9.32, P = 0.015) and noninvasive ventilation (OR: 6.17, 95% CI: 2.71–14.07, P < 0.001) were associated with a higher mortality rate while discharging on digoxin (OR: 0.14, 95% CI: 0.02–0.52, P = 0.011) was linked to lower mortality. The sole distinction among HF groups was observed in 12-month survival, with HFpEF patients having a superior survival rate of 91.7% compared to HFIEF patients at 77.5% and HFmrEF at 77.8% during this period. Conclusions: This study found significant differences in all-cause mortality at 12 months. Further research is warranted to better understand the mechanisms underlying these associations.

11 April 2023 in Annals of Clinical Cardiology
Verified
Journal Article
Open access
MEMohammed Adel Elsayed
Mohammed Adel Elsayed
MJMohammed Al Jarallah
Mohammed Al Jarallah
RDRaja Dashti
Raja Dashti
AMAhmed Said Taha Mousa
Ahmed Said Taha Mousa
SASulaiman Abdulrazzaq Sulaiman Al-Rushaidan
Sulaiman Abdulrazzaq Sulaiman Al-Rushaidan
RRRajesh Rajan
Rajesh Rajan
Crohn’s disease (CD) and Takayasu arteritis (TA) are distinct clinical entities. The likelihood of both diseases coexisting is low, and although CD co-occurs with all types of vasculitis, TA is the most common subtype. Herein, we report the case of a 31-year-old female who was diagnosed with TA following an initial diagnosis of CD. Coronary angiography revealed subtotal ostial left main stenosis and chronic total occlusion of the right coronary artery with collaterals from the left system. An urgent coronary artery bypass graft was planned.

1 July 2025 in Annals of Clinical Cardiology
Verified
Journal Article
Open access
EAEiman Abdullah Alrashid
Eiman Abdullah Alrashid
MAMalak Ghanim Alshammari
Malak Ghanim Alshammari
MAMaha A. Aldalmani
Maha A. Aldalmani
MJMohammed Al Jarallah
Mohammed Al Jarallah
YAYahya E. Alansari
Yahya E. Alansari
RRRajesh Rajan
Rajesh Rajan
A comparison of the recommendations for the diagnosis and management of mitral stenosis (MS), the major cause of valvular heart disease globally, from the European Society of Cardiology/European Association to the American College of Cardiology/American Heart Association 2020 guidelines. We systematically reviewed and contrasted the guidelines on the diagnosis and management of MS to appraise clinical judgment. A multimodel approach includes transesophageal echocardiogram (TEE), transthoracic echocardiogram (TTE), cardiac catheterization, exercise testing, and transcatheter mitral valve repair or replacement/transcatheter mitral valve implantation. Both guidelines agreed on medical therapy, which is anticoagulation, which has been shown to reduce the thromboembolic events in rheumatic MS. On the other hand, there was a subtle difference between both guidelines in staging the severity of MS. In addition, there was a disagreement regarding whether to perform a regular follow-up or to perform surgery.

1 January 2026 in Annals of Clinical Cardiology
Verified
Journal Article
Open access
MHMaryam Hussain
Maryam Hussain
FHFatmah Alzahraa Hussain
Fatmah Alzahraa Hussain
JAJenan Almdhaian
Jenan Almdhaian
MJMohammed Al Jarallah
Mohammed Al Jarallah
RDRaja Dashti
Raja Dashti
RRRajesh Rajan
Rajesh Rajan
We sought to compare recommendations from the European Society of Cardiology and the American College of Cardiology/American Heart Association guidelines, for the diagnosis and management of aortic regurgitation (AR), a major cause of valvular heart disease. Both guidelines agreed on a multidisciplinary approach to grade the mechanism and severity of AR. In both guidelines, surgical aortic valve (AV) replacement remains the predominant treatment modality after the surgical risk profile has been determined. Trans-catheter AV implantation is an alternative, but further data are needed to determine its efficacy. This review article focuses on AR and describes the prevalence, mechanisms, diagnosis, and treatment of AR.